EP2956176
MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.2.2014EP published:
27.6.2018EP application number:
14751357.6
EPO information:
European Patent Register
Max expiry date:
13.2.2034
Title:
MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS
Timeline
Today
14.2.2014EP application
27.6.2018EP Publication
Owner
Name:
Ionis Pharmaceuticals, Inc.Address:
2855 Gazelle Court, 92010, Carlsbad, CA, US
Inventor
Name:
ALEXANDER, Veronica, J.Address:
Carlsbad, CA, US
Name:
VINEY, Nicholas, J.Address:
Carlsbad, CA, US
Name:
WITZTUM, Joseph, L.Address:
San Diego, CA, US
Priority
Number:
201361764969 PDate:
14.2.2013Country:
US
Number:
201361880779 PDate:
20.9.2013Country:
US
Classification
Categories:
A61K 31/7088, C12N 15/113